Skip to main content
. 2014 Nov 21;4(6):454–463. doi: 10.1016/j.apsb.2014.10.005

Table 6.

DTE (%) and DTP (%) of optimized HP-SLNs i.n. and HP sol. i.n.

Formulation and route of administration DTE (%) DTP (%)
HP-SLNs 2362.43 95.77
HP sol. 1128.61 91.14